Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_50190 | 35 | 0.73 | Mlig455_035310 | Neo: - Age: - |
Mlig455_035310 {REF} {Length: 777} {NoTransDecoderORF} {RNA1509_20318} {RNA1310_14548.1} {RNA815_5654} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -4.074 | 1.205 | 1.00000 | 1.00000 | |
RegionR2 | 2.012 | 1.205 | 0.17667 | 0.52538 | |
RegionR3 | -0.74 | 1.205 | 0.91501 | 1.00000 | |
RegionR4 | 1.156 | 1.205 | 0.36047 | 0.68328 | |
RegionR5 | 1.918 | 1.205 | 0.08437 | 0.27183 | |
RegionR6 | 1.901 | 1.205 | 0.13792 | 0.66737 | |
RegionR7 | -3.074 | 1.205 | 1.00000 | 1.00000 | |
RegionR8 | 0.901 | 1.205 | 0.58732 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | 0.496 | 1.205 | 0.99996 | 1.00000 | |
RegenerationR2 | -1.136 | 1.205 | 0.25065 | 0.69735 | |
RegenerationR3 | 0.945 | 1.205 | 0.50195 | 0.85789 | |
RegenerationR4 | -0.497 | 1.205 | 0.67192 | 0.94313 | |
RegenerationR5 | -0.237 | 1.205 | 0.80515 | 0.98981 | |
RegenerationR6 | 0.17 | 1.205 | 0.85935 | 1.00000 | |
RegenerationBL | 1.546 | 1.205 | 0.34759 | 0.71497 | |
RegenerationTP | 0.814 | 1.205 | 0.64661 | 0.98709 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_50190 | 35 | 0.73 | Mlig455_035310 | Neo: - Age: - |
5 | - | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_035310 {REF} {Length: 777} {NoTransDecoderORF} {RNA1509_20318} {RNA1310_14548.1} {RNA815_5654} | |
2. | MligTC455_47353 | 154 | 3.21 | Mlig455_006450 | Neo: Irradiation Age: - |
1.672 | - | - | 0.963 | - | - | 0.709 | Mlig455_006450 {REF} {Length: 2834} {RNA1509_44124, RNA1509_56814} {RNA1310_22238, RNA1509_44124, RNA1509_56814} {RNA1509_44124, RNA1509_56814, RNA815_17842} | |
3. | MligTC455_30945 | 168 | 3.5 | Mlig455_020180 | Neo: - Age: - |
TUBB3 | 0.975 | - | - | - | 0.975 | - | - | Mlig455_020180 {REF} {Length: 2483} {Pfam: Tubulin/FtsZ family, GTPase domain [PF00091.27, score=234.4]; Tubulin C-terminal domain [PF03953.19, score=145.4]; Misato Segment II tubulin-like domain [PF10644.11, score=22.8]} {Human: ENSG00000258947, TUBB3, tubulin beta 3 class III, [RH, Score=803, Expect=0.0]} {Mouse: ENSMUSG00000062380, Tubb3, tubulin, beta 3 class III, [RH, Score=802, Expect=0.0]; ENSMUSG00000001473, Tubb6, tubulin, beta 6 class V, [RH, Score=788, Expect=0.0]} {Dmel: FBgn0003888, betaTub60D, beta-Tubulin at 60D, [RH, Score=794, Expect=0.0]} {Celegans: WBGene00000248, ben-1, Tubulin beta chain, [RH, Score=798, Expect=0.0]} {Smed: dd_Smed_v6_83_0_2, dd_Smed_v6_83_0_2, [Score=805, Expect=0.0]} {RNA1509_35307} {RNA1310_15130.1} {RNA815_4702.1} |
4. | MligTC455_42720 | 246 | 5.13 | Mlig455_024695, Mlig455_024719 | Neo: - |
CHRNA3 | 0.95 | - | - | 0.950 | - | - | - | Mlig455_024695 {REF} {Length: 2853} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=153.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=71.5]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=188, Expect=7e-54]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=186, Expect=3e-53]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=187, Expect=8e-54]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=187, Expect=1e-53]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=185, Expect=2e-53]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=179, Expect=9e-51]} {Dmel: FBgn0000036, nAChRalpha1, nicotinic Acetylcholine Receptor alpha1, [Score=194, Expect=4e-56]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=179, Expect=2e-50]} {Smed: dd_Smed_v6_2019_0_1, dd_Smed_v6_2019_0_1, [Score=314, Expect=2e-103]} {RNA1509_30530} {RNA1310_16567} {RNA815_2979.1} Mlig455_024719 {REF} {Length: 3783} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=153.5]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=80.8]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=192, Expect=8e-55]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=190, Expect=3e-54]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=193, Expect=2e-55]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=192, Expect=6e-55]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=187, Expect=1e-53]; ENSMUSG00000035594, Chrna5, cholinergic receptor, nicotinic, alpha polypeptide 5, [Score=187, Expect=2e-53]} {Dmel: FBgn0000036, nAChRalpha1, nicotinic Acetylcholine Receptor alpha1, [Score=196, Expect=6e-56]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=179, Expect=5e-50]} {Smed: dd_Smed_v6_2019_0_1, dd_Smed_v6_2019_0_1, [Score=316, Expect=1e-103]} {RNA1509_30530} {RNA1310_16567, RNA1509_30530} {RNA1509_30530, RNA815_2979.1} |